The Associated Factors With Fatigue in Older Adults Living in a Rest Home

February 19, 2020 updated by: Sevim ACARÖZ CANDAN, T.C. ORDU ÜNİVERSİTESİ

The Fatigue in Older Adults Living in a Rest Home: Prevalence and Associated Factors

Fatigue is an important and prevalent problem in older adults. The ratio of fatigue may rise in older adults who live in nursing homes/rest homes. In the literature, a few studies investigated the prevalence of fatigue, and there is no study explaining the associated factors. The aim of the present study is to investigate the prevalence of fatigue in rest home residents and to determine the associated variables with fatigue.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

92

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Altinordu
      • Ordu, Altinordu, Turkey, 52100
        • Sevim ACARÖZ CANDAN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The older adults living in a rest home

Description

Inclusion Criteria:

  • age older than 65 years
  • able to walk with/without walking device
  • living at a rest home for at least 12 months
  • being voluntary for all assessments

Exclusion Criteria:

  • had a cognitive problem (MMSE<24 scores)
  • had a neurologic disorder
  • had a cancer history
  • had uncontrolled cardiopulmonary dysfunction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Total sample
This group consists of older adults living in a rest home, who are proper for inclusion criteria
the fatigue will be determined through self reported questionnairres

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fall Severity Scale (FSS)
Time Frame: 5 minutes
The FSS is the most frequently used scale among the unidimensional scales which have been developed to assess fatigue. The scale rates the fatigue with nine items, For each item, the patient is asked to grade the fatigue level between 1 and 7, where 1 indicates strong disagreement and 7 indicates strong agreement. A score of 28 or higher generally indicates presence of fatigue.
5 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength assessment
Time Frame: 5 minutes
Quadriceps strength and handgrip strength will be measured by digital dynamometers named as Lafayette and Jamar dynamometers, respectively. Quadriceps strength will be measured in a sitting position with hip and knee flexed 90 degrees. The participants extend the knee and the examiner applies an opposite force to break this position. This test will be performed three times and the maximum value will be recorded in a kilogram. The handgrip strength will be assessed according to the American Society of Hand Therapists. The participants will be asked to squeeze as forcefull as possible the dynamometer. The maximum score of three trials will be recorded in kliograms.
5 minutes
Functional Capacity
Time Frame: 6-10 minutes
Six-minutes walk test will be used to evaluate the functional capacity or cardiorespiratory fitness. The participants will be walking in a 30-meter corridor for 6-minutes. If necessary the participants can use the walking assistive devices and take a rest. The total distance will be recorded in meters.
6-10 minutes
Physical Function
Time Frame: 5 minutes
Short Physical Performance Battery will be used to measure physical functioning. This battery includes 3 subdomains (gait speed, balance and chair stand test). The totatl score changes between 0 and 12. The higher score indicates better performance.
5 minutes
Boddy mass index
Time Frame: 2 minutes
The body measures (weight and height) will be assessed in kilograms and meters. The index will be calculated by dividing body weight by height squared.
2 minutes
Physical activity habits
Time Frame: 1 minutes
Physical activity habits will be determined with a question" How many times did you exercise for 30 minutes or more with a certain tempo?" This question will be recorded as a dichotomous variable, 1 indicates present physical activity habits (>2 times) and 0 no physical activity habits (<3 times).
1 minutes
Body mass
Time Frame: 30 seconds.
The weight will be measured in kilograms without shoes and within thin clothes
30 seconds.
Body Height
Time Frame: 30 seconds
The height will be determined in an erect standing position as centimeters.
30 seconds

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 23, 2019

Primary Completion (Actual)

January 31, 2020

Study Completion (Actual)

February 5, 2020

Study Registration Dates

First Submitted

January 28, 2020

First Submitted That Met QC Criteria

January 28, 2020

First Posted (Actual)

January 30, 2020

Study Record Updates

Last Update Posted (Actual)

February 21, 2020

Last Update Submitted That Met QC Criteria

February 19, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OrduU7

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fatigue

Clinical Trials on Self-reported questionairres

3
Subscribe